Will Hanmi reappear the success of its impotency drug, Palpal?
Hanmi Pharm, which has recorded the success in the impotency treatment ‘Viagra’ generic market, has raised curiosity in the pharmaceutical industry if it would revive the success.
The Korea Lilly’s ‘Cialis,’ recording the top market share in Korea, is scheduled to be expired in its substance pat...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
